Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

J Clin Invest. 2016 Jan;126(1):402-3. doi: 10.1172/JCI84828. Epub 2015 Nov 23.
No abstract available

Publication types

  • Published Erratum